Hearing Loss Trial, Recruiting (NCT03996824)

Hearing Loss Trial, Recruiting NCT03996824 Sponsor: Institut Pasteur Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT03996824 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
Your surgeon and you have agreed that surgery to remove a vestibular schwannoma (a type of non-cancerous ear tumour) is the right treatment for you
You have given your written agreement to take part in the trial
You are covered by French social security (note: AME coverage does not qualify)

Who may not be able to join:

The tumour has grown into certain parts of the inner ear (the vestibule or cochlea) — (confirm with trial site)
You are currently pregnant
You are under any form of legal guardianship or administrative oversight — (confirm with trial site)
You have a medical reason that would make participation unsafe — (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ghizlene Lahlou, Institut Pasteur

Phone: 33 1 45688891

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03996824

Sponsor: Institut Pasteur

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 33 1 45688891

More information: https://clinicaltrials.gov/study/NCT03996824

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
Your surgeon and you have agreed that surgery to remove a vestibular schwannoma (a type of non-cancerous ear tumour) is the right treatment for you
You have given your written agreement to take part in the trial
You are covered by French social security (note: AME coverage does not qualify)

Who may not be able to join:

The tumour has grown into certain parts of the inner ear (the vestibule or cochlea) — (confirm with trial site)
You are currently pregnant
You are under any form of legal guardianship or administrative oversight — (confirm with trial site)
You have a medical reason that would make participation unsafe — (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut Pasteur

Registry

ClinicalTrials.gov

Start date

19 February 2019

Est. completion

18 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

AAV transduction in inner ear cells

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov